Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Biotech ETF

+ Add to Watchlist

XBI:US

234.1000 USD 0.6600 0.28%

As of 20:04:04 ET on 05/22/2015.

Snapshot for SPDR S&P Biotech ETF (XBI)

Open: 232.3900 High - Low: 234.9500 - 231.3600 Primary Exchange: NYSE Arca
Volume: 557,377 52-Week Range: 128.5000 - 244.9800 Beta vs SPSIBITR: 0.9987

ETF Chart for XBI

No chart data available.
  • XBI:US 234.1000
  • 1D
  • 1M
  • 1Y
233.4400
Interactive XBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XBI

SPDR S&P Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to replicate the performance of the S&P Biotechnology Select Industry Index, an equal-weighed index. The Index tracks all the US common stocks listed on the NYSE, American Stock Exchange, NASDAQ National Market and NASDAQ Small Cap exchanges.

Inception Date: 2006-02-06 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER / MICHAEL FEEHILY
Web Site: www.spdrs.com

Fundamentals for XBI

NAV (on 2015-05-22) 234.0229
Assets (M) (on 2015-05-21) 2,345.3440
Shares out (M) 9.75
Market Cap (M) 2,282.48
% Premium 0.03
Average 52-Week % Premium 0.0051
Fund Leveraged N

Dividends for XBI

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2015-03-20) 0.2454
Dividend Yield (ttm) 0.82%

Performance for XBI

1-Month +0.63% 1-Year +85.40%
3-Month +9.84% 3-Year +43.21%
Year To Date +25.68% 5-Year +34.82%
Expense Ratio 0.35

Top Fund Holdings for XBI

Filing Date: 05/20/2015
Name Position Value % of Total
Synageva BioPharma Corp 218,978 46,729,905 2.000%
Sarepta Therapeutics Inc 1,661,478 43,597,183 1.866%
Alder Biopharmaceuticals Inc 924,804 37,695,011 1.614%
Dyax Corp 1,355,159 36,657,051 1.569%
Esperion Therapeutics Inc 315,136 36,275,305 1.553%
Ultragenyx Pharmaceutical Inc 409,657 34,624,210 1.482%
Bluebird Bio Inc 195,523 32,400,116 1.387%
Repligen Corp 748,735 31,439,383 1.346%
Momenta Pharmaceuticals Inc 1,574,412 30,370,407 1.300%
Amicus Therapeutics Inc 2,534,460 29,044,912 1.243%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil